Page last updated: 2024-08-17

hydroxyproline and bosutinib

hydroxyproline has been researched along with bosutinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jimenez, SA; Wermuth, PJ	1

Other Studies

1 other study(ies) available for hydroxyproline and bosutinib

Article	Year
Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib). PloS one, 2018, Volume: 13, Issue:5 Topics: Aniline Compounds; Animals; Hydroxyproline; Imatinib Mesylate; Lung; Mice; Mice, Transgenic; Nitriles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-abl; Pulmonary Fibrosis; Quinolines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Scleroderma, Systemic; Signal Transduction; Skin; src-Family Kinases; Transforming Growth Factor beta1	2018

Article

Year

Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib).

PloS one, 2018, Volume: 13, Issue:5

Topics: Aniline Compounds; Animals; Hydroxyproline; Imatinib Mesylate; Lung; Mice; Mice, Transgenic; Nitriles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-abl; Pulmonary Fibrosis; Quinolines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Scleroderma, Systemic; Signal Transduction; Skin; src-Family Kinases; Transforming Growth Factor beta1

2018